All You Need To Know About Nureca LTD IPO: Issue Details
All You Need To Know About Nureca LTD IPO: Issue Details
All You Need To Know About Nureca LTD IPO: Issue Details
Issue Details
Issue Amount : ` 100 Crores
Total shares for sale : 25,25,253 – 25,00,000 Equity Shares
Issue Period : Feb 15, 2021 - Feb 17, 2021
Face Value : �` 10 per share
Price Band : ` 396 to ` 400
Lot Size : �35 shares and in multiple thereafter
Registrar: Link Intime India Private Limited
Source : BRLM
Offer Breakup
Category Allocation Issue size (Shares) Issue size
(` in crore)
15
Issue closes on:
Wednesday, Feb 17, 2021
FEBRUARY
`
About the company
Nureca Ltd is a B2C company engaged in the business of home healthcare and
wellness products, which offers quality, durability, functionality, usability and
innovative designs. They enable their customers with tools to help them monitor
chronic ailments and other diseases, to improve their lifestyle. They believe in
innovation and catering new products to the ever-growing needs of the home
health care sector. They are a digital first company wherein they sell their
products through online channel partners such as e-commerce players,
distributors and retailer. Further, they also sell their products through their own
website drtrust.in. They have most of the product lines supporting the home
health market in India, making it a one-stop solution provider. Dr Trust is known
for its innovative products in the market, and, with the segment showing
significant potential for growth, the Company is positioned to show significant
growth. (Source: Frost & Sullivan Report).
They have a diversified product portfolio, which primarily cater to the home
healthcare sector. They provide an improved product mix to their customers and
their preferences thereby targeting a wider customer base. Their growth is further
driven by their ability to make available an assortment of quality products under
trusted brands built by their Company. The Home Health Market in India and
neighbouring countries is pegged at ₹20,757.0 crore in 2019 and is expected to
grow to ₹38,920.7 crore by 2025 at a CAGR 11.0%. The growth is driven by rising
awareness of Health and wellness, increasing spending power, growing burden of
chronic diseases, and the need for Healthcare stakeholders to reduce healthcare
costs (Source: Frost & Sullivan Report).
Currently, they classify their products portfolio under the following five categories
such as Chronic Device Products (BP monitors, pulse oximeters, thermometers
etc…), Orthopedic Products which includes rehabilitation products such as
wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric
massagers, Mother and Child Products (breast pumps, bottle sterilizers, bottle
warmers etc..), Nutrition Supplements (such as fish oil, multivitamins, probiotics,
biotin etc..) and Lifestyle Products (such as smart scales, aroma diffusers and
fitness tracker). They market and sell products across India through their own
website i.e. drtrust.in and third party e-commerce platforms, distributors and
retailers.
The following brands are currently being used by the Company for its existing
product range
Risks
` `
Their EBITDA on a consolidated basis was ₹9.76 Cr, ₹9.14 Cr and ₹4.39 Cr for
Fiscal 2020, 2019 and 2018, respectively and ₹50 Cr for the three months
ended September 30, 2020.
The restated profit after tax on a consolidated basis was ₹6.39 Cr, ₹6.23 Cr
and ₹3.11 Cr for Fiscal 2020, 2019 and 2018, respectively and ₹36.18 Cr for
the six months ended September 30, 2020. Net profit has grown at a CAGR
of 43.35% during Fiscal 2018 to 2020.
(in ` Crore)
HY Apr - Sep FY March FY March FY March
2020 2020 2019 2018
EBITDA
50.00 9.76 9.14 4.39
Profit after Tax 36.18 6.39 6.23 3.11
Source : RHP
Source : RHP. Revenue growth for FY 18 not available due to missing details regarding FY 17
Based on this financial year’s IPO data, it can be conveniently said that the
country represents a huge appetite for Initial Public Offers (or IPOs). In the
period April 2020 to Jan 2021, the country’s stock exchanges (both NSE and
BSE combined) witnessed 19 IPOs and raised proceeds worth Rs 34,003.78
crores in total. Some of the successful IPOs of 2020 were SBI Cards,
Mazagaon Dock, Rossari Biotech, Happiest Minds, and CAMS among
others. In December some of the most successful IPO launches were for
Burger King which saw a listing day gain of 130.67% and Mrs Bectors which
saw a listing gain of 106.79%. The same fervour continued in January with
4 back to back IPOs including major IPOs of Indigo paints and IRFC.
Although IRFC lost some steam, Indigo Paints posted a listing day gain of
109.31%
Last 10 IPO Performances
Date IPO Name Issue Size Retail Total Issue Price List Price Listing CMP on Current Gains
(` in crs) Subscription Subscription (in ₹) (in ₹) Gains(%) 8/2/2021 (in ₹) (%) 8-02-21
28-Jan-21 Stove Kraft Ltd 412.63 26.04 18.03 385 445.95 15.83 452.8 17.61
25-Jan-21 Home First Finance 1153.72 6.59 26.66 518 527.4 1.81 536.5 3.57
22-Jan-21 Indigo Paints Ltd 1170.56 6.5 54.84 1490 3118.65 109.31 2675.2 79.54
20-Jan-21 Indian Railway Finance Corp 4633 1.59 1.16 26 24.85 -4.42 25.75 (0.96)
23-Dec-20 Antony Waste Handling Cell Ltd 300.53 16.55 15.04 315 407.25 26.29 322.3 2.32
17-Dec-20 Mrs Bectors Food Specialities Ltd 540.54 29.33 198.02 288 501 106.79 410.25 42.45
4-Dec-20 Burger King India Ltd 796.5 68.15 156.65 60 115.35 130.67 150.7 151.17
11-Nov-20 Gland Pharma 6479.55 0.24 2.06 1500 1710 13.4 2321.25 54.75
22-Oct-20 Equitas Small Finance 517.6 2.08 1.95 33 31 -6.06 47.2 43.03
7-Oct-20 Likhitha Infra 61.2 23.71 9.51 120 130 8.42 210.65 75.54
Source : Moneycontrol
Investments in securities market are subject to market risks, please read all the related documents carefully before investing. SEBI Registration no.-INZ000240532, BSE-6707,
NSE-90165. visit www.paytmmoney.com for complete disclaimers. Regd Office:136, First Floor, Devika Tower, Nehru Place, New Delhi- 110019